Uxin Limited
Uxin Limited Fundamental Analysis
Uxin Limited (UXIN) shows strong financial fundamentals with a PE ratio of -18.11, profit margin of -10.69%, and ROE of 46.72%. The company generates $2.5B in annual revenue with strong year-over-year growth of 45.02%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 142.9/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.
Fundamental Health Score
We analyze UXIN's fundamental strength across five key dimensions:
Efficiency Score
WeakUXIN struggles to generate sufficient returns from assets.
Valuation Score
ExcellentUXIN trades at attractive valuation levels.
Growth Score
ExcellentUXIN delivers strong and consistent growth momentum.
Financial Health Score
ModerateUXIN shows balanced financial health with some risks.
Profitability Score
WeakUXIN struggles to sustain strong margins.
Key Financial Metrics
Is UXIN Expensive or Cheap?
P/E Ratio
UXIN trades at -18.11 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, UXIN's PEG of -0.09 indicates potential undervaluation.
Price to Book
The market values Uxin Limited at -3.52 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 40.68 times EBITDA. This signals the market has high growth expectations.
How Well Does UXIN Make Money?
Net Profit Margin
For every $100 in sales, Uxin Limited keeps $-10.69 as profit after all expenses.
Operating Margin
Core operations generate -7.13 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $46.72 in profit for every $100 of shareholder equity.
ROA
Uxin Limited generates $-1.76 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Uxin Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Uxin Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
UXIN converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-18.11
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
-3.52
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.87
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-8.73
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.72
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.47
vs 25 benchmark
ROA
Return on assets percentage
-0.02
vs 25 benchmark
ROCE
Return on capital employed
-0.02
vs 25 benchmark
How UXIN Stacks Against Its Sector Peers
| Metric | UXIN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -18.11 | 23.49 | Better (Cheaper) |
| ROE | 46.72% | 1160.00% | Weak |
| Net Margin | -10.69% | 672.00% | Weak |
| Debt/Equity | -8.73 | 0.73 | Strong (Low Leverage) |
| Current Ratio | 0.72 | 2.56 | Weak Liquidity |
| ROA | -1.76% | -8277.00% (disorted) | Weak |
UXIN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Uxin Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-49.01%
Industry Style: Cyclical, Growth, Discretionary
DecliningEPS CAGR
91.66%
Industry Style: Cyclical, Growth, Discretionary
High GrowthFCF CAGR
93.61%
Industry Style: Cyclical, Growth, Discretionary
High Growth